60752-82-1

Usage

Chemical structure

The compound consists of an azetidinium ring with a chloride ion attached, a prop-2-en-1-ylcarbamoyl group, and a 3-ethylpent-1-yn-3-yl group.

Pharmacological properties

The compound likely exhibits pharmacological properties, potentially acting as a neurotransmitter modulator or a potential therapeutic agent.

Biological activity

The specific biological activity and potential applications of the compound would need to be determined through further research and experimentation.

Molecular weight

The molecular weight of the compound is approximately 279.8 g/mol.

Solubility

The solubility of the compound in water and other solvents is not provided in the material, but it may be influenced by the presence of the azetidinium ring and the chloride ion.

Stability

The stability of the compound under various conditions, such as temperature, pH, and exposure to light, is not provided in the material and would need to be determined through further research.

Synthesis

The synthesis of the compound may involve the formation of the azetidinium ring, followed by the attachment of the prop-2-en-1-ylcarbamoyl group and the 3-ethylpent-1-yn-3-yl group. The specific synthetic route and reaction conditions would need to be determined through further research.

Reactivity

The reactivity of the compound with other molecules, such as enzymes or receptors, would need to be determined through further research and experimentation.

Toxicity

The toxicity of the compound, including potential side effects and safety concerns, would need to be determined through further research and experimentation.